EKF Diagnostics Holdings (EKF) Stock Statistics & Valuation Metrics

EKF Diagnostics Holdings has a market cap or net worth of £94.78M. The enterprise value is 110.41M.

EKF Diagnostics Holdings has 451,339,970 shares outstanding. The number of shares has decreased by -2.65% in one year.

EKF Diagnostics Holdings’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of EKF Diagnostics Holdings is ―. EKF Diagnostics Holdings’s PEG ratio is ―.

In the last 12 months, EKF Diagnostics Holdings had revenue of 52.61M and earned 2.35M in profits. Earnings per share was 0.01.

In the last 12 months, operating cash flow was 11.67M and capital expenditures -4.99M, giving a free cash flow of 6.68M billion.

EKF Diagnostics Holdings pays an annual dividend of 1.2p, resulting in a dividend yield of 5.71%

EKF Diagnostics Holdings upcoming earnings date is Sep 16, 2025, TBA Not Confirmed.

EKF Diagnostics Holdings as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, EKF Diagnostics Holdings has paid -600.00K in taxes.

EKF Diagnostics Holdings EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

EKF Diagnostics Holdings has £9.82M in cash and marketable securities with £4.10M in debt, giving a net cash position of -£9.58M billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for EKF Diagnostics Holdings is £29.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy